These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S. Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728 [Abstract] [Full Text] [Related]
5. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Anticancer Res; 2000 Dec; 20(6D):5195-8. PubMed ID: 11326694 [Abstract] [Full Text] [Related]
6. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K. Hepatogastroenterology; 2003 Dec; 50(51):696-9. PubMed ID: 12828063 [Abstract] [Full Text] [Related]
7. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. Anticancer Res; 1999 Dec; 19(4A):2443-50. PubMed ID: 10470173 [Abstract] [Full Text] [Related]
8. Prognostic value of serum sialyl Lewis(a), sialyl Lewis(x) and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patients. Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K. Tumour Biol; 2001 Dec; 22(2):115-22. PubMed ID: 11125284 [Abstract] [Full Text] [Related]
9. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J. Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125 [Abstract] [Full Text] [Related]
10. Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. Imada T, Rino Y, Hatori S, Takahashi M, Amano T, Kondo J, Suda T. Hepatogastroenterology; 1999 Mar 15; 46(25):208-14. PubMed ID: 10228794 [Abstract] [Full Text] [Related]
11. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer. Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Kurosaki N, Ayabe H, Arisawa K. Cancer Detect Prev; 2001 Mar 15; 25(3):299-308. PubMed ID: 11425272 [Abstract] [Full Text] [Related]
12. Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients. Nakagoe T, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Kurosaki N, Yasutake T, Ayabe H, Tagawa Y. Anticancer Res; 2000 Mar 15; 20(5C):3863-9. PubMed ID: 11268468 [Abstract] [Full Text] [Related]
13. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer. Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Kurosaki N, Yasutake T, Ayabe H, Arisawa K. J Exp Clin Cancer Res; 2001 Mar 15; 20(1):85-90. PubMed ID: 11370835 [Abstract] [Full Text] [Related]
14. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, Corsini A. J Surg Oncol; 1996 Aug 15; 62(4):239-44. PubMed ID: 8691835 [Abstract] [Full Text] [Related]
15. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. Uehara M, Manaka D, Baba S, Oji Y, Hirata K, Shimizu M, Noguchi M. Gan To Kagaku Ryoho; 2007 Sep 15; 34(9):1413-7. PubMed ID: 17876139 [Abstract] [Full Text] [Related]
16. The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study. Yüceyar S, Ertürk S, Dirican A, Cengiz A, Saner H. Int Surg; 1996 Sep 15; 81(2):136-9. PubMed ID: 8912078 [Abstract] [Full Text] [Related]
17. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A. Anticancer Res; 1997 Sep 15; 17(4B):2903-6. PubMed ID: 9329559 [Abstract] [Full Text] [Related]
18. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C. Cancer Detect Prev; 1995 Sep 15; 19(2):183-95. PubMed ID: 7750106 [Abstract] [Full Text] [Related]
19. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer. Eskelinen M, Pasanen P, Kulju A, Janatuinen E, Miettinen P, Poikolainen E, Tarvainen R, Nuutinen P, Pääkkönen M, Alhava E. Anticancer Res; 1994 Sep 15; 14(3B):1427-32. PubMed ID: 8067718 [Abstract] [Full Text] [Related]
20. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P. Eur J Surg Oncol; 2005 Mar 15; 31(2):164-9. PubMed ID: 15698733 [Abstract] [Full Text] [Related] Page: [Next] [New Search]